GLP-1 Agonists Linked to Hair Loss: What Predicts It?
Predictors and Characteristics of Hair Loss Among Users of GLP-1 Receptor Agonists: A Cross-Sectional Analysis.
Background
While GLP-1 receptor agonists (GLP-1 RAs) like semaglutide and tirzepatide are highly effective for type 2 diabetes and obesity, anecdotal reports suggest a potential link to hair loss. This side effect can significantly impact patient quality of life, yet current understanding of its prevalence, characteristics, and predictors among GLP-1 RA users remains limited, necessitating further investigation into this concerning adverse event.